Analysis of interactions between posaconazole/voriconazole and venetoclax
= 0.671). VEN combined with PCZ or VCZ resulted in significantly higher VEN exposure without a corresponding increase in severe hematological or gastrointestinal toxicity. This strategy effectively mitigates IFI risk without compromising the safety profile of VEN therapy.
Authors
- Jinxiu Lyu
- Chaoying Liu (ORCID: https://orcid.org/0000-0003-0484-9522)
- Pengzhou Hang (ORCID: https://orcid.org/0000-0002-4822-1027)
- W Xu
- Xiaoyan Xie
- Mei Sun
- Yibing Shi
Institutions
- China Pharmaceutical University (CN)
- Dalian Medical University (CN)
- Northern Jiangsu People's Hospital (CN)
Publication Details
- Journal
- Antimicrobial Agents and Chemotherapy
- Published
- 2026-03-31
- DOI
- https://doi.org/10.1128/aac.01101-25
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00